Genetics
•
Nov 14, 2025
•
12 min read
CRISPR 3.0: Scientists Achieve First Precision Gene Editing Without Off-Target Mutations
A landmark study from MIT and Broad Institute reveals a next-generation Cas enzyme that selectively targets DNA sequences with 99.99% accuracy, opening doors for safe therapeutic applications in humans.
DR
Dr. Elena Ross